Transcode Therapeutics
Price & Volume
Stats
See moreOpen | $7.44 |
Previous Close | $7.47 |
Day Range | $7.44-$7.77 |
52W Range | $6.08-$468.44 |
Market Cap | $6.7M |
Shares Short | 41,544 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$236.52 |
News
See moreYahoo Finance • 28 days ago
TransCode's TTX-MC138 To Enter Phase 2a Trial As Part Of Quantum Leap PRE-I-SPY Platform
Yahoo Finance • 3 months ago
Sector Update: Health Care Stocks Advance Late Afternoon
Yahoo Finance • 3 months ago
Sector Update: Health Care Stocks Advance Wednesday Afternoon
Yahoo Finance • 2 years ago
TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
About
CEO | Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D. |
CFO | Mr. Thomas A. Fitzgerald M.B.A. |
Address | 6 Liberty Square, Boston, MA, United States, 02109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 7 |
